Stephen Freedland, MD, is director of the Center for Integrated Research in Cancer and Lifestyle and associate director for training and education at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai.
Enzalutamide Combo Improves OS in Prostate Cancer Without Sacrificing Quality of Life: Stephen Freedland, MD
Stephen Freedland, MD, of Cedars-Sinai, discussed enzalutamide and leuprolide's potential to improve overall survival without sacrificing quality of life in prostate cancer.